Back to BlackRock Finance, Inc.FDMT
FDMTShowing 1 of 3 quarters
Position history for BlackRock Finance, Inc.'s holdings in 4D MOLECULAR THERAPEUTICS IN
BlackRock Finance, Inc. holds 4.9M shares of FDMT (4D MOLECULAR THERAPEUTICS IN), worth $102.8M as of 2024-Q2. The position was increased (+14.3% shares). FDMT represents 0.0% of BlackRock Finance, Inc.'s portfolio.
Current Value
$102.8M
Current Shares
4.9M
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of FDMT: VIKING GLOBAL INVESTORS LP, RA CAPITAL MANAGEMENT, L.P.
Upgrade to Pro to see multi-quarter position history and trends. View plans